Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 231 participants.

Also called NCT02833948

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose diagnostic
Phase
Phase 3
Enrolled
  • 231 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02833948
Other papers using this trial's data
  • Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement The New England journal of medicine, 2020-01-09 DOI, PubMed 31733182

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada, Denmark, Germany, Netherlands, Sweden, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02833948. Randomized; single masking; primary purpose diagnostic. Start 2016-05 (registry gives no type); primary completion 2018-12 (actual). Results posted on 2020-01-18.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)
Acronym
GALILEO-4D
Condition
Aortic Valve Stenosis
Condition
Cardiovascular Diseases
Condition
Heart Valve Diseases
Condition
Ventricular Outflow Obstruction
Condition
Thrombosis
Intervention (Drug)
Acetylsalicylic acid
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Rivaroxaban
Lead sponsor
ECRI bv (class: industry)
Collaborator
Copenhagen University Hospital, Rigshospitalet (class: other)
Collaborator
Bayer (class: industry)
Collaborator
Cardialysis BV (class: industry)

Record details

Record id
cardio:ct-nct02833948
Content hash
1d660771d11f354c419bc1395c194269b393f2de41d4119265df73574f209653